Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
WuXi AppTec is a global company providing a broad portfolio of R&D and manufacturing services that enable the pharmaceutical, biotech, and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. Its comprehensive, integrated services span the entire drug development lifecycle, from discovery chemistry and biology to preclinical testing, clinical trial services, and commercial-scale manufacturing for small molecules, cell therapies, and gene therapies. WuXi AppTec is committed to accelerating the development of new medicines and therapies to benefit patients globally.
Serves as the main operational command center, overseeing global strategy, R&D initiatives, manufacturing operations, and administrative functions. It's a key site for drug discovery, process development, and clinical research coordination.
The Shanghai campus comprises multiple state-of-the-art research laboratories, advanced analytical facilities, pilot plants, and cGMP manufacturing sites, designed to support integrated drug development programs.
The work culture at WuXi AppTec's Shanghai headquarters is dynamic and science-driven, emphasizing innovation, collaboration, and a strong customer-centric approach. Employees often work in a fast-paced environment focused on delivering high-quality results for global clients.
Shanghai is strategically vital as it's where WuXi AppTec was founded and has grown into a global leader. It anchors its extensive Asia-Pacific operations and serves as a critical node in its international service network.
WuXi AppTec operates an extensive global network with over 30 sites and offices located across China, the United States, Europe (including Germany, Switzerland, the UK, and Ireland), Israel, South Korea, and Japan. This geographically diverse presence enables the company to support a wide array of functions worldwide, including: integrated drug discovery services, small molecule CRDMO (Contract Research, Development and Manufacturing Organization) services, cell and gene therapy CTDMO (Contract Testing, Development and Manufacturing Organization) services, biologics CRDMO services (often in conjunction with its affiliate WuXi Biologics), and comprehensive medical device testing services. This global footprint allows WuXi AppTec to offer localized support while leveraging its worldwide expertise and capacity for its international clientele.
288 Fute Zhong Lu, Waigaoqiao Free Trade Zone
Shanghai
Shanghai
China
Address: Philadelphia Navy Yard, e.g., 400 Rouse Blvd, Philadelphia, PA 19112, USA (one of several sites in the Navy Yard)
Critical center for WuXi AppTec's North American strategy, providing advanced therapy solutions and testing services to a high concentration of biotech and pharmaceutical companies.
Address: e.g., 1265 Kennard Street, St. Paul, MN 55108, USA (represents their medical device testing facilities in the area)
Serves as a center of excellence for medical device testing, supporting the innovation and regulatory compliance needs of the medtech industry in North America and beyond.
Address: FraunhoferstraĂźe 22, 82152 Martinsried, Germany
Enhances WuXi AppTec's service capabilities within Europe, providing localized, specialized testing support for European drug development programs and clinical trials.
Address: Multiple sites, e.g., Wuxi Biologics Campus (sister company, but significant regional presence relevant to AppTec's ecosystem)
A foundational site for the WuXi group, contributing significantly to its integrated service platform and large-scale manufacturing capabilities in China.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, WuXi AppTec' leadership includes:
WuXi AppTec has been backed by several prominent investors over the years, including:
WuXi AppTec's core C-suite executive team, particularly its Co-CEO leadership structure, has maintained stability over the past 12 months. Based on publicly available information and company announcements, there have been no major widely reported new hires or departures at the highest executive levels (e.g., Co-CEOs or direct reports to the board with equivalent C-suite titles). The company generally announces significant leadership changes through official press releases or regulatory filings.
Discover the tools WuXi AppTec uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
WuXi AppTec, like many large global corporations, utilizes standardized email formats for its employees. The most common format typically involves a combination of the employee's first and last name. Knowing this pattern can be useful for professional communication.
firstname_lastname@wuxiapptec.com
Format
richard_lee@wuxiapptec.com
Example
90%
Success rate
Business Wire • April 25, 2024
WuXi AppTec released its 2023 annual and Q1 2024 financial results, reporting continued growth. The company highlighted its commitment to its CRDMO (contract research, development and manufacturing organization) and CTDMO (contract testing, development and manufacturing organization) enabling platforms, despite a complex global environment. Revenue for Q1 2024 was RMB 7.98 billion....more
Reuters (and other major news outlets) • May 15, 2024
WuXi AppTec, among other Chinese biotech companies, has been under scrutiny in the United States due to the proposed BIOSECURE Act. The bill, advanced by a U.S. House committee, aims to prevent federally funded medical providers from using services of these companies over national security concerns. WuXi AppTec has consistently stated it poses no national security risk and is committed to supporting its global clients....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including WuXi AppTec, are just a search away.